LINC02769

Across TCGA pan-cancer cohorts, LINC02769 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC02769’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02769 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02769 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD, LUAD, and HNSC are the cancer types where LINC02769 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02769 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−0.216	.006	5	view →
LUAD	All	All	+0.104	.002	4	view →
HNSC	All	II,III,IV	+0.056	.019	3	view →
LUSC	All	II,III,IV	+0.079	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC02769–COAD

Open the COAD breakdown →